QuickMD HRT Review: What the Published $79 Visit Actually Buys — and the 8-State Limit

Q: How much is a QuickMD HRT visit?

QuickMD’s dedicated menopause page publishes $79 per visit, while its separate hormone-therapy medication directory publishes $99 per visit. Confirm the price shown in the booking flow before payment. The visit fee does not include medication or labs.

Q: Does QuickMD prescribe estradiol patches?

Yes. QuickMD lists estradiol patches at a $64 starting price per 30-day supply. FDA-approved estradiol patch products exist, but QuickMD does not publish the exact product, manufacturer, NDC, strength, frequency, or final price that every patient will receive.

The HRT Index Editorial TeamIndependent women's health research

Last reviewed:August 24, 2026

Editorial research — not medically reviewed by a clinician. Why this label

Last updated: August 24, 2026 · Last verified: August 24, 2026 · By The HRT Index Editorial Team. Educational research, not medical advice, and not reviewed by a clinician. See our medical review policy. Full disclosure.

Before you trust the $79

QuickMD may fit a cash-pay patient who wants a pay-per-visit prescription discussion in one of eight listed states. Compare your state, care depth, labs, medication route, and likely follow-up cost before paying.

Find My HRT Path

QuickMD is a legitimate, low-commitment option for cash-pay women in the eight states where its directory lists menopause care. This QuickMD HRT review found a published $79 visit price, $24–$64 home-delivery medications, typically required labs, quarterly follow-ups, and no refund after a completed visit. It works best when you need a prescriber, not a bundled menopause team.

By the editorial team at The HRT Index · Independent research. Not medical advice. Not medically reviewed by a clinician.

Last verified August 2026 · QuickMD pricing, policies, formulary pages, support articles, state availability, and clinical claims were re-checked on August 24, 2026.

We have no affiliate relationship with QuickMD. We earn nothing if you book with them. We say that up front because it explains why this review reads the way it does.

Before you trust the $79: QuickMD’s dedicated menopause page publishes $79 per visit, while its broader hormone-therapy medication directory publishes $99 per visit. We treat $79 as the current published menopause-program price, not a guaranteed checkout charge. Confirm the number displayed in the booking flow before you pay.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

QuickMD HRT Review: is it worth it?

QuickMD is worth considering if you live in one of its eight listed menopause-care states, expect to pay cash for the visit, and want access without a membership. The tradeoff is blunt: labs cost extra, follow-ups are typically every three months, the same clinician is not guaranteed, and a completed visit is nonrefundable even when no prescription is written.

Best for / not for you if

QuickMD is a strong fit if you:

Live in California, Florida, Georgia, New York, Oklahoma, Pennsylvania, Texas, or Washington
Want a pay-per-visit model with no membership or automatic monthly care charge
Are comfortable paying the visit fee without insurance
Want to discuss conventional estradiol or progestogen dosage forms and will confirm the exact product dispensed
Have a reasonably clear idea of the symptoms and medication route you want to discuss
Value speed and accept that same-day availability and two-day shipping are provider-stated, not guarantees
Are prepared to book and pay for follow-ups, typically every three months

QuickMD is not your starting point if you:

Live in any of the other 42 states or Washington, DC, based on QuickMD’s current state directory
Need a provider to bill insurance for the visit
Want labs included in one published price
Need the same assigned menopause clinician at every appointment
Want proactive check-ins between visits rather than booking each follow-up yourself
Have unexplained bleeding after menopause or a personal history that makes systemic hormone therapy more complex, including certain estrogen-sensitive cancers, blood clots, stroke, heart attack, or liver disease; start with an in-person clinician who can evaluate the full picture

QuickMD HRT at a glance

Decision fact	What QuickMD publishes	What the primary-source check found
Visit price	$79 on the menopause page	A separate hormone-therapy directory says $99; confirm checkout
Subscription	None	Verified: visits are paid one at a time
States listing hormone therapy	Not stated on the menopause sales page	8 states in QuickMD’s state directory
Typical MHT follow-up	Every 3 months or as the clinician advises	Verified in QuickMD’s August 2026 support article
Home-delivery medication prices	$24–$64 per 30-day supply	Cash prices; patch is labeled a starting price
Labs	Typically required before treatment	Not included in the visit price and no public lab price
Visit insurance	Not accepted	A visit summary may be submitted for possible out-of-network reimbursement
Prescription insurance	May apply at a chosen retail pharmacy	Home-delivery partner pricing is cash-pay
Completed visit with no prescription	No refund	Verified
Conservative 365-day published-cadence scenarios	Not calculated by QuickMD	$863–$1,511 before labs using the $79 price and five visits
Assigned clinician	Not guaranteed	QuickMD is clinician-agnostic; any available clinician can access prior notes
Support	Live chat, phone, and email	Verified

Source: QuickMD menopause hormone therapy, hormone-therapy medication directory, follow-up policy, insurance policy, and refund policy. Accessed August 24, 2026.

The damaging admission: the price is not as simple as the headline

QuickMD’s best feature is also the thing its public pages make harder than it needs to be.

The dedicated menopause page says $79 per visit. The broader hormone-therapy directory says $99 per visit. QuickMD also publishes medication prices, but those are separate from the visit. Labs are separate again. Ongoing MHT requires follow-ups, typically every three months.

So no: this is not “$79 HRT.”

It is a $79-or-$99 clinical door, plus medication, plus labs, plus follow-up visits.

That does not make QuickMD a bad deal. It makes the headline incomplete.

And the reason it can still be a good deal is the same reason the care model looks sparse: QuickMD does not wrap the visit in a monthly membership. You pay for access one appointment at a time. If that is the exact layer you need, the stripped-down model is the point.

Does that sound like your situation? Check QuickMD’s current state availability and displayed visit price before entering payment. We earn nothing from the link.

Provider-stated versus independently checked

Claim	Status	What it means before you pay
“$79 per visit”	Provider-stated, with a conflict	The dedicated MHT page says $79; another current QuickMD page says $99
“Same-day appointments”	Provider-stated	Appointment inventory changes in real time
“Free 2-day shipping”	Provider-stated	Confirm eligibility, fulfillment pharmacy, and delivery estimate for your order
MHT in eight states	Verified from QuickMD’s directory	Check the booking flow because service maps can change
Follow-up every three months	Verified from QuickMD’s policy	A conservative 365-day budget includes the initial visit plus follow-ups around months 3, 6, 9, and 12
Labs typically required	Verified from QuickMD’s policy	Ask which tests, where they are performed, and what they cost
Visit fees are not billed to insurance	Verified	Medication insurance is a separate question
Testosterone cream is compounded	Verified	QuickMD lists 2 mg/mL and 3 mg/mL compounded creams
Conventional estradiol and progesterone forms are available	Verified at category level	Exact manufacturer, strength, NDC, and FDA approval status of the product you receive still require confirmation
Completed visit is nonrefundable	Verified	You pay for clinical judgment, not a guaranteed prescription

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

How should you read the facts in this review?

Every material claim on this page is labeled by what it actually is: a fact verified from a primary source, something QuickMD states about itself, arithmetic using published prices, or an editorial fit judgment. That separation matters because a provider’s advertised speed is not the same kind of evidence as an FDA label or a written refund policy.

Verified fact — read on a current QuickMD policy page, an FDA or DEA source, an official drug label, or peer-reviewed guidance.
Provider-stated — QuickMD says it; we did not independently test the service, shipping time, or clinical experience.
Our math — arithmetic using QuickMD’s published prices and the assumptions printed beside it. It is not a quote.
Our opinion — an editorial fit judgment based on the verified facts above it.
Not verified — a detail the public pages do not establish, such as the exact manufacturer and NDC that will arrive in one patient’s package.

That is the difference between a review and a sales page.

Is QuickMD HRT available in my state?

QuickMD’s state directory lists menopause hormone therapy in eight states: California, Florida, Georgia, New York, Oklahoma, Pennsylvania, Texas, and Washington. Its other services cover more of the country, but the dedicated menopause sales page does not place this eight-state limit beside the advertised visit price.

We checked every state entry in QuickMD’s public directory on August 24, 2026.

State	Hormone therapy listed?
California	✅ Yes
Florida	✅ Yes
Georgia	✅ Yes
New York	✅ Yes
Oklahoma	✅ Yes
Pennsylvania	✅ Yes
Texas	✅ Yes
Washington	✅ Yes
The other 42 states and Washington, DC	❌ Not listed

Verified fact: QuickMD state directory, checked August 24, 2026.

Eight is a harsh limit. It is also not proof of a bait and switch.

QuickMD publishes the state directory. The company is not pretending the service exists everywhere once you reach the directory. The problem is simpler and more useful to know: the page selling the visit does not put the geography beside the price. A woman can read the menopause page, medication page, and price grid without seeing that most states are excluded.

That gap matters because booking in the wrong state is not frictionless to fix.

QuickMD’s matching-ID rule is its rule, not a federal matching-ID law

QuickMD says you must be physically located in the same state that issued your valid photo ID at the time of the appointment.

That matching-ID rule should not be mistaken for a universal federal matching-ID law.

The underlying telehealth rule is that the clinician must be authorized to practice where the patient is physically located. Federal telehealth guidance tells providers to verify patient location, and state licensure requirements attach to that location. A universal federal rule requiring the patient’s photo-ID state to match the physical state is not stated in that guidance.

QuickMD’s matching-ID requirement is therefore a stricter booking rule published by QuickMD.

Practical example: a Texas driver’s license does not make a QuickMD appointment workable while you are physically in Ohio, and QuickMD also says the service must be available in the state shown on the ID.

Sources: QuickMD booking eligibility and HHS telehealth licensing guidance.

What happens when you book in the wrong state?

QuickMD’s refund policy says Patient Support may reschedule the visit after an additional $35 administrative fee when the patient booked in the wrong state. “May” matters. This is not an automatic promise that the service will become available.

Before you enter a card:

Open QuickMD’s booking flow.
Select the state where you will physically be during the appointment.
Confirm that menopause hormone therapy appears.
Confirm that the ID requirement will not block the visit.
Read the displayed visit price before paying.

Do not book urgent care or another service hoping to turn it into an HRT appointment. Pick the correct service before payment.

Not in one of those eight states?
That is women in 42 states and Washington, DC, and it is not a dead end. It just means QuickMD is not your door yet.
Use Find My HRT Path to narrow the providers that serve your state, fit your insurance or cash-pay situation, and match the level of clinical support you want.

What does QuickMD actually prescribe for menopause?

QuickMD’s public price grid lists eleven products, while its support formulary also names estradiol gel, medroxyprogesterone, and paroxetine. Conventional FDA-approved products exist in several of the listed estradiol and progestogen dosage forms, but QuickMD does not publish the exact manufacturer or NDC it will dispense. Testosterone and estriol creams are explicitly compounded.

The public menu can support product-category conclusions. It cannot support a product-level FDA claim before the exact product is identified.

A drug name is not an FDA approval. Approval applies to a specific finished product with a specific application, manufacturer, strength, dosage form, labeling, and quality controls. Seeing “estradiol patch” on a telehealth menu does not prove which patch will arrive.

So the accurate distinction is:

QuickMD lists conventional dosage forms for which FDA-approved products exist.
QuickMD separately lists compounded testosterone and compounded estriol.
The exact status of what you receive is confirmed from the label, manufacturer, and NDC after the prescription is selected and filled.

That is not nitpicking. It is the difference between FDA-approved and “a molecule that also appears in approved products.”

QuickMD medication price and regulatory ledger

QuickMD listing	Published cash price / 30 days	What it is	Regulatory conclusion we can support
Estradiol tablets	$24	Systemic oral estrogen	FDA-approved oral estradiol products exist; exact dispensed product and NDC not published
Progesterone capsules	$29	Oral progesterone/progestogen support	FDA-approved progesterone capsules exist; exact product and prescribed regimen not published
Estradiol + norethindrone	$44	Combined systemic estrogen and progestin	FDA-approved combination tablets exist; exact dispensed product not published
Estradiol vaginal cream	$39	Local vaginal estrogen	FDA-approved vaginal estradiol creams exist; exact dispensed product not published
Estradiol vaginal inserts	$59	Local vaginal estrogen	FDA-approved vaginal estradiol inserts exist; exact dispensed product not published
Estradiol patches	$64 starting price	Systemic transdermal estrogen	FDA-approved estradiol patches exist; exact product, strength, frequency, and final price not published
Norethindrone tablets	$29	Progestin	QuickMD lists the category, but the price grid does not publish the exact salt, strength, product, or intended regimen
Loestrin Fe	$34	Combined oral contraceptive	FDA-approved contraceptive product; not standard menopausal hormone therapy
Minoxidil tablets	$24	Hair-loss medication; not a hormone	Oral minoxidil is FDA-approved for severe hypertension; use for hair loss is off-label
Testosterone cream	$59	Topical androgen	Compounded 2 mg/mL and 3 mg/mL products; not FDA-approved; testosterone is Schedule III
Estriol face cream	$59	Facial topical estrogen	Compounded 0.3% product; not FDA-approved; no FDA-approved estriol drug exists in the US

QuickMD prices: menopause hormone therapy page, accessed August 24, 2026. Formulary details: QuickMD prescribing list. Product-level references: DailyMed oral estradiol, DailyMed estradiol patch, DailyMed progesterone, and DailyMed estradiol/norethindrone.

QuickMD’s support formulary also lists:

Estradiol gel
Medroxyprogesterone
Paroxetine as a nonhormonal option for hot flashes

Those do not have published cash prices in the eleven-item menopause price grid we checked.

What FDA-approved means here — and what compounded means

FDA-approved means the specific drug product completed the FDA approval process for its labeled use. The FDA reviews the application’s evidence, manufacturing information, labeling, and quality requirements.

Compounded means a pharmacy prepares a medication for an individual prescription. Compounded drugs are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality before marketing, and it does not have evidence that compounded “bioidentical” hormones are safer or more effective than FDA-approved hormone therapy.

The FDA also states that there are no FDA-approved drugs containing estriol in the United States.

Compounding is legal and can meet a real clinical need when an appropriate approved product is unavailable or unsuitable. It is still a different regulatory category. The two categories should never be blurred, and a compounded product should never borrow the evidence or approval status of an FDA-approved product.

Sources: FDA menopause guidance and The Menopause Society on hormone therapy.

1. Conventional dosage forms are a QuickMD strength — but check the label

Estradiol tablets, patches, vaginal cream, vaginal inserts, oral progesterone, and combined estradiol/norethindrone are not proprietary mystery categories. FDA-approved products exist in those forms, and retail pharmacies dispense them every day.

That is a meaningful advantage for a woman who wants a conventional prescription pathway.

But do not let “FDA-approved products exist” turn into “QuickMD definitely sends an FDA-approved generic.” The public price grid does not identify the manufacturer or NDC. Ask where the prescription will be sent, then check the pharmacy label and product information.

Minoxidil is not a hormone. Loestrin Fe is a contraceptive. Estriol face cream is a compounded skin product that QuickMD itself says is not a substitute for systemic hormone therapy when broader menopause symptoms are present.

They may belong in a broader women’s midlife-care menu. They do not all belong in a count of core menopausal hormone-therapy options.

That distinction matters when you compare formularies across providers. A menu with eleven priced items does not mean eleven interchangeable MHT regimens.

3. There is still $108 a year sitting in plain sight

QuickMD publishes:

Estradiol tablets at $24
Progesterone capsules at $29
Estradiol + norethindrone tablets at $44

Medication-only arithmetic:

Separate oral estradiol + progesterone: $53 per month
Combination estradiol + norethindrone: $44 per month
Difference: $9 per month, or $108 per year

That is a useful question to raise. It is not a recommendation to swap.

Micronized progesterone and norethindrone are different progestogens with different dosing, contraindications, and side-effect considerations. The cheaper line is not automatically the better line. The original value here is seeing both prices side by side before the appointment so you can ask why one regimen fits you better than the other.

How much does QuickMD HRT really cost?

Using QuickMD’s published $79 menopause visit, its typical three-month follow-up cadence, and cash home-delivery medication prices, a conservative 365-day budget runs from $863 for vaginal estradiol cream to $1,511 for an estradiol patch plus progesterone before labs. If checkout shows $99 instead, add $100 across five visits.

QuickMD publishes the visit price. It publishes the medication prices. It now publishes a typical follow-up cadence.

It still does not put the year together.

So we did.

What you would pay under the published follow-up cadence

Regimen	First 30 days	Through day 90	Conservative first 365 days
Vaginal estradiol cream only	$118	$275	$863
Estradiol + norethindrone combination tablet	$123	$290	$923
Oral estradiol + progesterone	$132	$317	$1,031
Estradiol patch + progesterone	$172	$437	$1,511
Add compounded testosterone cream	+$59	+$177	+$708

Our math, not a quote. Assumptions:

The $79 price shown on QuickMD’s dedicated menopause page
One initial visit
Follow-ups around months 3, 6, 9, and 12
Five paid visits in the conservative first-365-day planning case
Twelve 30-day cash home-delivery medication fills
QuickMD labels each medication row as a 30-day supply; actual refill timing depends on the dispensed quantity and prescribed schedule
The testosterone add-on row adds medication cost only; it does not assume that testing or visit needs remain unchanged
Estradiol patch at its published starting price
No dose change, shipping surcharge, tax, replacement order, or medication outside the row
Labs excluded because QuickMD does not publish the price
If the clinician schedules the month-12 follow-up just outside your first 365 days, subtract one visit charge from the annual column

What the $79 versus $99 conflict changes

Public visit price used	First 30-day visit cost	Two visits through day 90	Five visits in the conservative 365-day case
$79	$79	$158	$395
$99	$99	$198	$495
Difference	+$20	+$40	+$100

The conflict does not turn an $863 planning case into a $2,000 year. It still matters because the whole appeal is price transparency.

Confirm it before payment. Do not assume the lower page wins.

Labs cost real money and are not in the headline

QuickMD says labs are typically required before starting MHT. Its support article names hormone levels and thyroid testing and says a mammogram or bone-density scan may sometimes enter the evaluation. Its menopause page describes a broader panel that may include CBC, CMP, lipids, thyroid, and vitamin D.

The public pages do not give one required panel or one price.

That means “$79 visit” cannot answer your first-year budget by itself.

Ask these questions in writing:

Which tests are required for the medication route I am considering?
Are the tests required before the first prescription or after the initial consult?
Who orders them?
Which lab will perform them?
What is the self-pay price?
Can recent results from another clinician be uploaded for review?
Are mammography or bone-density records required for me, and how recent must they be?

QuickMD’s MHT lab policy says its team will coordinate testing but does not publish a menopause-specific laboratory contact. For pre-booking questions, use Patient Support through live chat, phone, or support@quick.md.

The patch price is a floor, not a ceiling

The estradiol patch is the only product in QuickMD’s menopause grid labeled “starting price.”

The published $64 can therefore support a floor. It cannot support a universal quote.

Patch brand, strength, application frequency, quantity, pharmacy, insurance coverage, and substitution can change the actual cost. Ask which product and strength the $64 covers before you build a budget around it.

QuickMD does publish a follow-up schedule now

QuickMD does publish a follow-up schedule.

QuickMD’s support article, updated August 7, 2026, says follow-up visits are required for ongoing MHT and are typically scheduled every three months or as advised by the clinician. Any available QuickMD clinician can conduct them and access prior notes.

That one policy changes the cost math more than any other published detail on this page.

A woman who budgets one or two visits for the year is likely understating the published care cadence. For a conservative 365-day budget, count the initial appointment plus follow-ups around months 3, 6, 9, and 12. If the month-12 appointment falls just outside that window, subtract one visit.

The honest reframe: the visit buys access, not automatically cheap medication

This is the part we would want a friend to say without flinching.

QuickMD’s home-delivery prices are not automatically the lowest pharmacy prices. They are published cash prices tied to convenience. A local pharmacy may be cheaper or more expensive. Insurance may cover some or all of a prescription sent to your chosen pharmacy. A discount card may change the cash number again.

What QuickMD sells well is the door:

A licensed clinician authorized in your state
A phone or video appointment
No referral
No visit-fee insurance claim
No membership
A prescription sent to your pharmacy when clinically appropriate
A published cash-delivery fallback for eligible medications

For a woman who has spent weeks trying to find someone willing to discuss menopause care, that access can be the whole problem.

Just do not book believing $79 is the whole treatment.

You are buying a faster door. The rest still has to be counted.

If the numbers and care model fit
Check current pricing and book the correct menopause service with QuickMD. Confirm your state and the displayed visit price before payment. We earn nothing from that link.
Not sure whether a patch, pill, or local vaginal treatment is the right category to discuss? Use Find My HRT Path before you pay for the wrong kind of care.

What happens if the QuickMD clinician does not prescribe?

You do not get the completed-visit fee back. QuickMD says a visit is complete once you have been seen, and no refund is due when the clinician decides the requested medication is not appropriate. Cancellations normally become account credit, and late cancellation, no-show, or wrong-state mistakes can trigger a $35 deduction or fee.

This is the fear that stops people from clicking, so here it is without perfume.

What happens	What QuickMD’s current policy says
You complete the visit and the clinician declines the requested medication	No refund and no credit
You cancel more than one hour before the visit	Visit cost becomes account credit
You no-show or cancel within one hour	Credit is reduced by a $35 fee
You booked in the wrong state	Support may reschedule after an additional $35 administrative fee
The selected service cannot be provided	QuickMD may issue a full credit
Medication has not shipped	A credit may be available under the policy
Medication has shipped	No return, refund, or credit because prescription medication cannot be returned
Medication is damaged or lost	QuickMD may provide a partial credit or replacement with documentation
The clinician is more than 15 minutes late	The policy provides a full account credit
You want a card refund instead of credit	Request it within 30 days of the original charge
You dispute a completed visit or delivered medication	QuickMD says a $25 administrative fee may be assessed; fraud chargebacks can lead to dismissal

Verified fact: QuickMD Refunds & Cancellations Policy, read August 24, 2026.

Standard visit credits must be used within 12 months. A first-time patient’s full credit after an incomplete visit expires after 30 days. To move an eligible credit back to the original card, request the refund within 30 days of the original charge.

QuickMD’s current policy also says a disputed charge or chargeback for a successfully completed visit or delivered medication may trigger a $25 administrative fee. Fraud chargebacks may be grounds for dismissal from the service.

Is the no-prescription rule a red flag?

No. It is a hard policy, but it is not proof that the service is illegitimate.

You are paying for a clinician’s time and judgment, not purchasing a guaranteed prescription. A clinician who can say no is doing the job.

The damaging part is not that a clinician can decline. The damaging part is that the fee is gone after the completed visit, and QuickMD’s short intake-to-appointment model may give you less room to resolve eligibility questions before payment than a program that screens first.

That is why the questions on this page belong before checkout.

Is QuickMD legit for HRT?

Yes. QuickMD is a real telemedicine platform using US-licensed medical professionals who are authorized in the patient’s location, including MDs, DOs, and nurse practitioners depending on state and service. It names a Chief Medical Officer for Women’s Health and publishes its medication, lab, follow-up, insurance, and refund rules. The real tradeoff is care depth, not legitimacy.

What checks out

Licensed clinicians. QuickMD says its clinicians are licensed in the United States and authorized to practice in the state where the patient is located. Its clinician network can include MDs, DOs, and NPs depending on state and service.

A named women’s-health leader. QuickMD identifies Dr. Sheryl Ross, MD, as Chief Medical Officer, Women’s Health.

Published policies. The company publicly states the completed-visit refund rule, quarterly MHT follow-up cadence, typical lab requirement, insurance split, clinician-agnostic model, support channels, and the compounded status of testosterone and estriol.

A visible certification claim. QuickMD displays LegitScript certification. We treat that as one commercial-compliance signal, not a substitute for evaluating the actual MHT service.

A real support operation. QuickMD’s current support page says live chat, phone, and email are available seven days a week, with published hours.

Scale. QuickMD says it has completed more than one million visits and sees more than 50,000 patients per month. Those are provider-stated company-wide numbers, not independently audited menopause outcomes.

What the scale does not prove

QuickMD’s company-wide volume spans addiction treatment, menopause care, weight loss, mental health, and urgent care. Its own About page says addiction treatment is at the center of the business and reports more than one million addiction-treatment visits. Those numbers do not tell you how many women used the menopause service, stayed on treatment, received the same clinician, or had medication adjustments handled well.

That distinction is not cynical. It is basic evidence hygiene.

The same problem applies to reviews.

Why there is no QuickMD HRT star score or testimonial here

QuickMD’s public review footprint mixes different service lines. A review about addiction treatment, urgent care, or weight-loss fulfillment is not evidence about an estradiol-prescribing experience.

QuickMD also publishes patient testimonials on its own site. Provider-selected testimonials are marketing material, and the examples visible on its company pages are not a clean, representative menopause dataset.

So we did not:

Invent an HRT star rating
Average unrelated service reviews into a menopause score
Use a treatment-outcome testimonial to imply efficacy
Pretend we tested the service as patients
Present a company-wide satisfaction number as an MHT result

That costs us an easy social-proof section.

Good.

A review should lose a persuasive asset before it borrows proof from the wrong patients.

Our verdict on legitimacy

QuickMD is legitimate. It is not a mystery storefront, and the “is this a pill mill?” fear is aimed at the wrong issue.

The actual question is whether its transaction-style care model fits you.

That is a much more interesting question, because the answer can be yes for one woman and absolutely not for the next.

What does QuickMD not do well?

QuickMD sells pay-per-visit access, not an assigned menopause care team. Follow-ups are required and typically quarterly, but the same clinician is not guaranteed, labs are not bundled into a published price, and QuickMD does not publish a proactive between-visit monitoring program. That is a real gap for someone starting treatment with a complicated history.

Here is the flaw, stated accurately.

QuickMD does not promise you the same menopause clinician every time. It calls itself clinician-agnostic by design. Any available qualified clinician can see the visit history and prior notes.

That gives QuickMD speed.

It also means continuity is record-based rather than relationship-based.

QuickMD now publishes a real follow-up cadence, so the original claim that there is no schedule was wrong. Follow-ups are typically every three months. But you still have to book them, and the public model is a series of paid visits rather than an assigned team checking in on a fixed week-six or week-eight schedule.

Labs are not bundled. The exact panel and cash price are not published. Medication fulfillment can move between a retail pharmacy and home-delivery partners. The public pages do not promise one clinician who owns the whole plan from first symptom inventory through dose stabilization.

For a woman starting systemic hormone therapy for the first time, dealing with unexplained bleeding, sorting through a complex personal history, or already struggling on a regimen, that can be the wrong trade.

If you want an assigned clinician, coordinated labs, and proactive follow-up, do not choose QuickMD just because the first visit price is lower. A more managed model may cost more and still be the cheaper decision if it prevents fragmented care and repeated appointments.

Find My HRT Path routes that situation toward programs built around continuity and flags when an in-person evaluation is the better first move.

What QuickMD gets in return for skipping the membership layer

Now the pivot.

Because QuickMD does not bundle a monthly care program, you are not signing up for a subscription. There is no membership to cancel, no monthly platform charge between visits, and no minimum term published for MHT.

That does not mean $79 is the entire commitment. Ongoing treatment means medication, labs when required, and quarterly follow-up visits.

It means the commitment is visible and episodic instead of wrapped in a recurring membership.

For a woman who:

Already has recent records
Understands the symptoms she wants evaluated
Knows the route she wants to discuss
Does not need an assigned clinician
Accepts quarterly pay-per-visit follow-up
Wants the prescription sent to a retail pharmacy
Lives in one of the eight states

the care-management layer she would fund elsewhere may not be the thing she needs.

QuickMD’s advantage is not that the medication is automatically identical or cheaper. The exact product must still be confirmed.

Its advantage is that she can buy clinical access one visit at a time without joining a program.

Does that sound like your situation?
Check the live menopause booking flow and current visit price. Make sure hormone therapy appears for your state before entering payment.
Read this and thought, “No, I do want someone watching the first few months”? That is not a failure of nerve. Use Find My HRT Path to compare the managed-care lane instead.

Should you get testosterone cream from QuickMD?

QuickMD sells compounded testosterone cream for $59 per 30-day supply and lists 2 mg/mL and 3 mg/mL strengths. Testosterone is a Schedule III controlled substance, and no FDA-approved testosterone product is specifically indicated for women in the United States. The strongest evidence supports postmenopausal HSDD after a formal biopsychosocial assessment—not broad treatment of energy, mood, muscle, bone, or cognition.

This is the section where we would ask you to slow down.

What QuickMD publishes on the sales page — and what sits elsewhere

QuickMD’s testosterone sales page advertises possible help with:

Mood
Energy
Libido
Muscle mass
Bone density
Cognitive function

The sales page puts the benefit story in the shopping path.

QuickMD’s support center supplies the missing regulatory detail. It lists compounded testosterone topical cream and publishes separate pages for 2 mg/mL and 3 mg/mL strengths.

That disclosure is useful. It also belongs beside the price, not several clicks away.

QuickMD should get credit for naming the compounded status and strengths in public support materials. It should not get credit for making a woman hunt for the part that changes how the product should be evaluated.

The claim-by-claim evidence check

The primary reference is the Global Consensus Position Statement on the Use of Testosterone Therapy for Women, developed by major international endocrine, sexual-medicine, and menopause organizations.

QuickMD-advertised benefit	What the consensus evidence found	Evidence verdict
Libido	A moderate benefit for postmenopausal women diagnosed with HSDD after assessment; trials averaged about one additional satisfying sexual event per month over placebo	✅ Supported for a narrow indication
Mood	No demonstrated effect on depressed mood	❌ Not supported
Energy	No demonstrated effect on general wellbeing; “energy” is not established as a separate evidence-based indication	❌ Not supported
Muscle mass	No statistically significant effect on lean body mass or muscle strength at physiologic doses	❌ Not supported
Bone density	No supported effect at the spine, hip, or femoral neck at 12 months	❌ Not supported
Cognitive function	Evidence is insufficient to support enhanced cognition or delayed decline	⚠️ Unestablished

HSDD means hypoactive sexual desire disorder: low sexual desire that persists, causes personal distress, and is diagnosed after other biological, psychological, relationship, medication, and health factors are assessed.

Libido/HSDD is the one claim on that six-item sales list with high-grade evidence behind it.

The rest are unsupported or unestablished as testosterone indications for women.

We are grading the marketing copy, not claiming every QuickMD clinician will prescribe for every advertised symptom. A licensed clinician still decides whether testosterone is appropriate.

No US women’s product does not make compounded cream guideline-equivalent

The guideline exception is easy to overread.

There is no FDA-approved testosterone product specifically indicated for women in the United States. That is true.

The consensus statement says an approved male transdermal formulation may be prescribed off-label at a female dose when an appropriate women’s product is unavailable, with levels kept in the physiologic female range. It also says compounded testosterone cannot be recommended for HSDD because efficacy and safety evidence are insufficient, and its summary states that the panel recommended against compounded testosterone.

The absence of a US-approved women’s product does not turn a compounded cream into the regulatory or evidence equivalent of an approved product.

It means the prescribing decision requires more care, not less.

The statement leaves a narrow practical exception when no authorized equivalent is available and a compounded product is needed. In that situation, it calls for a pharmacy meeting appropriate purity and manufacturing standards and dosing that remains in the physiologic female range.

That is the fair reading. Not “compounded is forbidden.” Not “the exception makes it equivalent.”

Testosterone is Schedule III

Testosterone is a Schedule III controlled substance under US federal law.

It requires a valid prescription from an authorized clinician. It should be stored securely and never shared. The controlled-substance status does not disappear because the patient is a woman, the dose is lower, or the medication is a topical cream.

The QuickMD visit does not guarantee a testosterone prescription.

Also, a blood testosterone level does not diagnose HSDD. The consensus statement says no circulating androgen cutoff distinguishes women with sexual dysfunction from women without it. Baseline and follow-up testing are used for safe dosing and monitoring, not as a permission slip generated by one “low” number.

Want the full evidence picture before deciding? Read Testosterone for Women: What the Evidence Actually Supports and Testosterone for Women Cost by Route.

Regulatory sources: DEA drug scheduling, FDA menopause guidance, and ISSWSH clinical practice guideline. QuickMD product sources: testosterone cream, 2 mg/mL support page, and 3 mg/mL support page.

Do you need lab work for QuickMD HRT?

Probably. QuickMD’s current policy says labs are typically required before MHT, but it does not publish one universal panel or one price. That is QuickMD’s treatment workflow, not a universal rule that hormone blood tests are required to diagnose menopause; in a classic case after age 45, menopause is generally diagnosed clinically.

QuickMD’s support article names:

Hormone levels
Thyroid testing
Sometimes mammography
Sometimes bone-density testing

Its menopause landing page describes a broader evaluation that may include:

Complete blood count
Comprehensive metabolic panel
Lipid panel
Thyroid testing
Vitamin D
Other tests based on the patient

Those two pages do not establish that every woman needs every item.

They establish one practical fact: do not assume the $79 visit is enough to start treatment.

QuickMD’s lab policy and menopause diagnosis are different questions

A provider can require testing for its treatment process even when a blood test is not necessary to diagnose menopause itself.

Peer-reviewed clinical guidance says that, in the classic situation after age 45, menopause is a clinical diagnosis based on menstrual history and age; routine hormone measurements are not indicated to make the diagnosis.

That does not make QuickMD’s policy automatically wrong. It means “QuickMD requires labs” should not be translated into “every woman needs hormone tests to prove she is menopausal.”

Ask what decision each test is meant to inform.

Send these questions before you pay

QuickMD’s MHT lab policy says its team will coordinate testing. For pre-booking questions, use Patient Support through the website, by phone, or at support@quick.md.

Send:

For the medication route I want to discuss, which tests are required?
Can the clinician review recent results from my primary-care doctor?
Must testing be completed before a prescription is considered?
Which lab company will be used?
What is the exact self-pay price?
Will I receive a written order I can take elsewhere?
Are mammogram or bone-density records required in my case?
Will I pay another visit fee to review the results?

That last question belongs in the budget. A “lab cost” can create a second cost if results require another paid appointment sooner than expected.

Sources: QuickMD lab policy, QuickMD menopause page, and clinical-practice guideline abstract on menopause diagnosis.

Does QuickMD take insurance for HRT?

QuickMD does not bill insurance for visit fees. It says you receive a visit summary that may be submitted for possible out-of-network reimbursement, while prescriptions sent to your chosen retail pharmacy may be covered by insurance. QuickMD’s home-delivery partners use cash-pay pricing, so “QuickMD does not take insurance” is true for visits but incomplete for medication.

Here is the accurate split.

Cost	Can insurance apply?	What to verify
QuickMD visit fee	QuickMD does not bill insurance	Ask your plan about out-of-network telehealth reimbursement
Visit summary	May be submitted to an insurer	Confirm whether it includes the CPT and diagnosis codes your plan requires
Prescription at your chosen pharmacy	Insurance may cover some or all	Check formulary, tier, prior authorization, quantity limits, and preferred product
QuickMD home delivery	Direct cash-pay through eligible partners	Compare the cash price with your retail-pharmacy cost
Prior authorization	QuickMD says Support can submit documentation	QuickMD says it will submit within three business days after a request
HSA/FSA	QuickMD says cards can typically be used for visits	Confirm eligibility with the plan administrator

QuickMD identifies Honeybee Health and The Pharmacy Hub as home-delivery partners for direct cash payment. Another support page says some MHT medications ship through Honeybee Health and that the order confirmation identifies the pharmacy.

That means the pharmacy network is not entirely undisclosed.

What remains undisclosed before a specific order is placed is the exact pharmacy, manufacturer, product, NDC, and final quantity for that patient.

The visit-summary question can decide whether reimbursement is real

QuickMD says it provides a “visit summary.” It does not promise on the public insurance page that the document is an itemized superbill containing every code an insurer may require.

If out-of-network reimbursement is part of your decision, do not settle for “you can submit it.”

Ask:

Does the document include the rendering clinician?
Does it include the service date?
Does it include CPT or HCPCS codes?
Does it include diagnosis codes?
Does it include QuickMD’s tax ID and billing information?
Can QuickMD provide a sample with personal information removed?

Possible reimbursement is not the same thing as a reimbursable claim.

If insurance is what makes care possible

Then QuickMD’s visit model may be the wrong door.

An insurance-billed menopause platform can look more expensive on a self-pay page and cost less after the plan processes the visit. Midi Health, for example, states that it is in-network with most major plans nationwide, while coverage, deductibles, copays, and coinsurance vary by the specific plan. Its published self-pay rates are $250 for an initial visit and $150 for a return visit.

That is a different model, not an automatic winner.

But for an insured woman, comparing a $79 cash visit only against a $250 self-pay rate is the wrong comparison. The real comparison is $79 cash versus her actual copay, deductible position, lab coverage, and prescription benefits.

If insurance billing decides whether care is affordable, start with the insurance lane. Find My HRT Path filters the decision by state, payment model, medication preference, and desired care depth.

Sources: QuickMD insurance policy, QuickMD medication-insurance options, QuickMD shipping source, and Midi pricing and insurance.

How does QuickMD compare with other online HRT care models?

QuickMD competes on low-commitment access rather than bundled care. It is cheaper at the visit level than a self-pay menopause specialty clinic, but it does not bill insurance for visits, bundle labs into one public price, or promise an assigned clinician. The right comparison is transaction versus relationship—not one headline price versus another.

Forget brand names for a minute. There are four different products hiding under “online HRT.”

Care model	Current example	What you pay for	What it solves best	What to watch
Pay per visit	QuickMD	Each clinical visit; medication and labs separate	Fast access without a membership	Eight-state MHT list, price conflict, quarterly paid follow-ups
Insurance-billed specialty care	Midi Health	Insurance cost-sharing or published self-pay visits	Menopause-focused care with broader availability	Plan-specific coverage; labs and prescriptions are separate costs
Bundled medication subscription	Winona	Monthly plan that can include physician access and medication	Predictable recurring model and ongoing messaging	Menu includes FDA-approved and compounded options; exact formulation matters
Menopause subscription	Sesame	Subscription; medication is separate	Provider choice, video visits, unlimited messaging, and basic labs when ordered	Medication is separate; lab-routing and direct-pay exceptions apply in some states

Provider-stated model details verified August 24, 2026 from Midi, Winona, and Sesame. Exact prices and availability can change; check the provider’s live page.

When QuickMD wins

QuickMD is strongest when all of these are true:

You live in one of the eight listed states
You are paying cash for the visit
You do not want a subscription
You are comfortable with clinician-agnostic continuity
You can handle labs outside the visit price
You want the prescription sent to a pharmacy you choose
You accept quarterly follow-up visits
You are not relying on testosterone marketing claims that outrun the evidence

That is a narrower winner than “best online HRT.”

It is also a real winner.

When QuickMD loses

QuickMD loses the fit test when:

It does not serve your state
Your insurance would make a specialist platform cheaper
You want an assigned clinician
You want basic labs bundled
You want proactive messaging and dose-adjustment support between visits
You need a complex in-person workup
You want an exact all-in monthly number
You want a provider whose public testosterone pathway follows the guideline preference away from compounded products

Do not force QuickMD to be the product it is not.

The provider-specific searcher came here for confirmation, not redirection. If QuickMD fits the list above, there is no reason to apologize for choosing the leaner model.

If it does not, the lower first visit price will not rescue it.

A quick symptom-route check before you compare companies

Only vaginal dryness, irritation, urinary symptoms, or pain with sex? Low-dose vaginal estrogen is a local treatment category. The Menopause Society says very little enters the bloodstream compared with systemic therapy. QuickMD lists vaginal cream at $39 and inserts at $59. A clinician still needs to decide whether local treatment fits the symptoms and history.

Hot flashes, night sweats, or broader systemic symptoms? That is a different treatment conversation from local vaginal therapy. Compare systemic routes and whether a progestogen is needed based on uterine status and the prescribed regimen.

Want testosterone specifically? Do not pick a provider from the price row alone. Start with the HSDD evidence, compounded status, monitoring plan, exact concentration, pharmacy, and controlled-substance requirements.

Want a pure pay-per-visit comparison? See online HRT providers that charge per visit.

What did The HRT Index verify?

We re-checked QuickMD’s current public pages on August 24, 2026 and separated what the company actually publishes from what still requires checkout, intake, a clinician, or a pharmacy label. The page’s original value is the assembled state, price, follow-up, refund, insurance, formulary, and testosterone evidence in one reproducible ledger.

Verified from current primary sources

The dedicated menopause page publishes $79 per visit
The hormone-therapy medication directory publishes $99 per visit
The menopause price grid lists eleven cash medication prices from $24 to $64
Estradiol patch pricing is labeled a starting price
QuickMD’s state directory lists hormone therapy in eight states
QuickMD requires physical presence in the state that issued the patient’s photo ID
MHT follow-ups are required and typically occur every three months
The same clinician is not required; prior notes are visible to available clinicians
QuickMD clinicians may include MDs, DOs, and NPs depending on state and service
Labs are typically required before MHT under QuickMD’s policy
Visit fees are not billed to insurance
Prescriptions sent to a chosen retail pharmacy may use insurance
HSA/FSA cards can typically be used for visits, subject to the plan
Honeybee Health and The Pharmacy Hub are named cash-pay home-delivery partners
Live chat, phone, and email support are published
Completed visits are not refundable when no prescription is issued
Late cancellation, no-show, and wrong-state mistakes can involve $35
Disputed charges or chargebacks for completed visits or delivered medication may trigger a $25 administrative fee
Testosterone cream is compounded and listed in 2 mg/mL and 3 mg/mL strengths
Estriol face cream is compounded at 0.3%
Testosterone is a federal Schedule III controlled substance
No FDA-approved estriol drug exists in the United States
No FDA-approved testosterone product is specifically indicated for women in the United States
High-grade testosterone evidence is limited to postmenopausal HSDD after assessment
QuickMD’s broad testosterone claims for mood, energy, muscle, bone, and cognition are not supported by the consensus evidence reviewed

What still needs confirmation before payment or dispensing

The exact visit price displayed in your booking flow
Whether MHT is visible for your state in the live booking flow
The exact clinician type available for your appointment
The exact lab panel required for your history and requested treatment
The lab company, timing, and cash price
Whether recent outside results can be used
Whether result review creates another paid visit
The exact manufacturer, product, strength, NDC, and quantity dispensed
The actual price of your patch strength
The specific home-delivery pharmacy assigned to your order
Whether the visit summary contains all fields required for an out-of-network claim
Your insurance formulary coverage and prior-authorization rules
Your personal follow-up cadence if the clinician recommends something other than every three months
MHT-specific satisfaction, retention, symptom, or fulfillment outcomes

The questions to copy before you book

Which QuickMD page price will I be charged: $79 or $99?
Is menopause hormone therapy available while I am physically in my state?
Will my ID state satisfy QuickMD’s booking rule?
Which labs are required before a prescription is considered?
What will those labs cost?
Can my recent records and lab results be reviewed?
How often will I need a paid follow-up?
Can I choose the same clinician again?
Can the prescription be sent to my local pharmacy?
Which exact product, manufacturer, strength, and quantity will be prescribed?
Is the product FDA-approved or compounded?
Which pharmacy will fill a compounded prescription?
Does my visit summary include billing and diagnosis codes?
What happens to my fee if the clinician decides treatment is not appropriate?

How this review was produced

We read QuickMD’s menopause page, hormone-therapy directory, state directory, formulary, product support pages, clinician policy, follow-up policy, laboratory policy, insurance policy, pharmacy support pages, contact page, and refund terms on the same date.

We then:

Recalculated the first 30 days, first 90 days, and a conservative first 365 days using the published follow-up cadence
Separated the $79 and $99 public price claims
Separated visit insurance from prescription insurance
Separated FDA-approved product categories from the exact unverified product that may be dispensed
Separated compounded testosterone and estriol from conventional dosage forms
Checked testosterone marketing claims against the international consensus statement
Checked controlled-substance scheduling against the DEA
Removed unrelated testimonials and cross-service star math
Marked every detail that still depends on checkout, clinical judgment, or a pharmacy label

We have not used QuickMD as patients. We did not test appointment speed or shipping. QuickMD did not pay for this review and did not approve it.

This review follows The HRT Index Verification Standard: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule — top providers monthly, the full roster quarterly.

We assess providers on five things, in this order: clinical legitimacy, care quality, medication fit, price transparency, access.

The “Last verified” date changes only when the commercial and regulatory facts are re-checked, not when a sentence is polished.

Frequently asked questions

Is QuickMD a legitimate telehealth provider for HRT?

Yes. QuickMD uses US-licensed clinicians authorized in the patient’s location and publishes current policies for MHT follow-up, labs, insurance, medication, and refunds. Its limitations are the eight-state service list, cash-only visit fee, clinician-agnostic model, unbundled labs, and nonrefundable completed visit—not whether the company is real.

How much is a QuickMD HRT visit?

QuickMD’s dedicated menopause page publishes $79 per visit, while its separate hormone-therapy medication directory publishes $99 per visit. Confirm the price shown in the booking flow before payment. The visit fee does not include medication or labs.

What states does QuickMD offer hormone therapy in?

QuickMD’s state directory lists hormone therapy in California, Florida, Georgia, New York, Oklahoma, Pennsylvania, Texas, and Washington. Check the live booking flow because state availability can change after this review’s August 2026 verification date.

How much does QuickMD HRT cost per month?

There is no single monthly price. Home-delivery medication prices run from $24 to $64 per 30-day supply, while visits are separate and MHT follow-ups are typically every three months. Our conservative first-365-day scenarios using the published $79 visit range from $863 to $1,511 before labs.

Does QuickMD take insurance for menopause treatment?

QuickMD does not bill insurance for visit fees. It provides a visit summary for possible out-of-network reimbursement, and a prescription sent to your chosen retail pharmacy may be covered by insurance. Home-delivery partner pricing is cash-pay.

Can I use an HSA or FSA for QuickMD?

QuickMD says HSA/FSA cards can typically be used for visits. Eligibility depends on the plan, so confirm with the administrator. Prescription and laboratory eligibility can also depend on how and where each service is paid.

Does QuickMD prescribe estradiol patches?

Yes. QuickMD lists estradiol patches at a $64 starting price per 30-day supply. FDA-approved estradiol patch products exist, but QuickMD does not publish the exact product, manufacturer, NDC, strength, frequency, or final price that every patient will receive.

Does QuickMD prescribe vaginal estrogen?

Yes. QuickMD lists estradiol vaginal cream at $39 and vaginal inserts at $59 per 30-day supply. FDA-approved products exist in both categories, but confirm the exact dispensed product. Local vaginal therapy and systemic HRT answer different symptom patterns.

Does QuickMD prescribe testosterone to women?

Yes. QuickMD lists compounded testosterone cream at $59 per 30-day supply and publishes 2 mg/mL and 3 mg/mL support pages. Testosterone is Schedule III, requires a valid prescription, and is not guaranteed. No FDA-approved testosterone product is specifically indicated for women in the United States.

Is QuickMD’s testosterone cream FDA-approved?

No. QuickMD identifies the creams as compounded. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before marketing. The international consensus statement recommends against compounded testosterone for HSDD because efficacy and safety evidence are insufficient, while allowing a narrow practical exception when no authorized equivalent is available and a compounded product is needed.

Does testosterone help women with energy, mood, muscle, bone density, or brain fog?

The consensus evidence does not support those broad claims. The sole evidence-based indication identified by the international statement is HSDD in postmenopausal women after formal biopsychosocial assessment. Evidence shows no effect on general wellbeing or depressed mood, no significant effect on lean mass or strength, no supported bone-density benefit at 12 months, and insufficient cognitive evidence.

Do I need blood work before QuickMD prescribes HRT?

QuickMD says labs are typically required before MHT. It does not publish one universal panel or one price. Routine hormone testing is not generally required to diagnose menopause in a classic case after age 45, so ask what each test is for and whether recent results can be reviewed.

Is there a subscription or membership with QuickMD?

No. QuickMD’s MHT model is pay per visit, with medication and labs separate. Ongoing treatment is still recurring in practice because follow-up visits are required, typically every three months, and prescriptions need renewal and monitoring.

Will I see the same QuickMD clinician every time?

Not necessarily. QuickMD describes itself as clinician-agnostic and says any available qualified clinician can access prior visit history and notes. You may be able to choose a clinician from available appointments, but continuity is not guaranteed.

What happens if the QuickMD clinician will not prescribe HRT?

You do not receive a refund after a completed visit. QuickMD states that completing a visit does not guarantee a prescription and that the fee is not returned when the clinician decides the requested medication is inappropriate.

Can QuickMD send the prescription to my local pharmacy?

Yes. QuickMD says prescriptions can be sent to the patient’s chosen pharmacy, where insurance may cover some or all of the cost. Home delivery is a separate cash-pay option through eligible pharmacy partners.

How fast can I get HRT from QuickMD?

QuickMD advertises same-day appointments and free two-day home-delivery shipping. Those are provider-stated service claims, not guarantees. Appointment inventory, lab requirements, clinical eligibility, pharmacy processing, prior authorization, stock, and shipping can all affect the actual timeline.

Why does QuickMD use MHT instead of HRT?

MHT means menopause hormone therapy. HRT means hormone replacement therapy. They commonly describe the same treatment category in menopause care, though many clinical organizations prefer “hormone therapy” or “menopause hormone therapy.” This page uses both because women search both.

What is the difference between QuickMD and Midi Health?

QuickMD is a cash-pay, pay-per-visit model with MHT listed in eight states and no insurance billing for visits. Midi says it is available in all 50 states and in-network with most major insurance plans, with $250 initial and $150 return self-pay rates. QuickMD fits a cash payer who wants low-commitment access; Midi may fit an insured patient who wants menopause-specialty care.

Is QuickMD the cheapest online HRT provider?

Not in every situation. Its first visit price is low, but labs, quarterly visits, medication, and the $79/$99 conflict change the year. Insurance at another provider or lower retail-pharmacy medication pricing can beat QuickMD’s cash total. Compare the whole year, not one button.

What is the bottom line on QuickMD HRT?

QuickMD is a legitimate, low-commitment route to a menopause prescription discussion for a specific woman: she lives in one of eight listed states, is paying cash for the visit, does not need an assigned clinician, accepts quarterly follow-ups, and wants access without a membership. That is a real use case, and she is not being reckless for choosing it.

The strongest case for QuickMD is not “the cheapest HRT in America.”

It is this:

You can pay for a licensed clinician one visit at a time, discuss conventional estradiol and progestogen dosage forms, send an appropriate prescription to a pharmacy you choose, and avoid joining a subscription.

The damaging admissions remain:

The public visit price conflicts between $79 and $99
Menopause care is listed in only eight states
Labs are typically required and not publicly priced
Follow-ups are typically every three months and separately paid
The same clinician is not guaranteed
A completed visit is nonrefundable
Exact FDA approval status cannot be inferred until the dispensed product is identified
QuickMD’s compounded testosterone marketing reaches far beyond the strongest evidence

For the right woman, those are acceptable tradeoffs.

For the wrong woman, they are the entire decision.

If you are outside the eight states, need insurance billed for the visit, want labs bundled, need an assigned clinician, or want someone proactively watching the first months, QuickMD is the wrong door. No amount of low first-visit pricing fixes a care-model mismatch.

Before you spend anything:

Check your state in the live menopause booking flow.
Confirm whether the screen says $79 or $99.
Get the lab requirement and cash price in writing.
For a conservative 365-day budget, count the initial visit plus follow-ups around months 3, 6, 9, and 12.
Ask for the exact product, manufacturer, strength, NDC, and pharmacy.
Read the refund policy before the appointment starts.
Treat compounded testosterone as a separate, evidence-limited, Schedule III decision—not an add-on for vague low energy.

Women in 42 states and Washington, DC cannot use QuickMD’s menopause service under the current state directory.

If that is you, you did not waste your time.

You eliminated one option before it took your money. That is what a good decision page is supposed to help you do.

Still not sure which HRT program is right for you? Take our free 60-second matching quiz.

Sources

QuickMD — commercial facts and policies, all accessed August 24, 2026

Clinical and regulatory

Care-model comparison — provider-stated, accessed August 24, 2026

The HRT Index is reader-supported. We may earn a commission from some provider links on this site, always disclosed at the point of the link. We have no affiliate relationship with QuickMD and earn nothing from any QuickMD link on this page. Our reviews are not for sale and providers cannot pay for placement.

This page is educational research and is not medical advice. It has not been reviewed by a clinician. Hormone therapy carries risks and benefits that depend on personal and family medical history, age, symptoms, route, dose, and other factors. Talk to a licensed clinician before starting, stopping, or changing treatment.

Put this QuickMD review in context

Compare the best online HRT providers, see other pay-per-visit HRT options, read the Musely HRT review, review Midi's insurance model, or use Find My HRT Path before choosing a route.

Keep reading: